117.21
2.02%
+2.32
Pre-mercato:
117.68
0.47
+0.40%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Perché ORCL Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$114.89
Aprire:
$117.04
Volume 24 ore:
8.28M
Capitalizzazione di mercato:
$322.15B
Reddito:
$52.51B
Utile/perdita netta:
$10.64B
Rapporto P/E:
34.88
EPS:
3.36
Flusso di cassa netto:
$12.26B
1 W Prestazione:
+2.03%
1M Prestazione:
-7.32%
6M Prestazione:
+16.74%
1 anno Prestazione:
+25.08%
Oracle Corp. Stock (ORCL) Company Profile
Nome
Oracle Corp.
Settore
Industria
Telefono
650-506-7000
Indirizzo
500 Oracle Parkway, Redwood City, CA
Oracle Corp. Stock (ORCL) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-04-18 | Iniziato | Oppenheimer | Perform |
2024-03-21 | Iniziato | KeyBanc Capital Markets | Overweight |
2024-03-14 | Aggiornamento | Argus | Hold → Buy |
2024-03-12 | Reiterato | BMO Capital Markets | Market Perform |
2024-03-12 | Aggiornamento | William Blair | Mkt Perform → Outperform |
2023-12-12 | Reiterato | BMO Capital Markets | Market Perform |
2023-11-13 | Aggiornamento | Edward Jones | Hold → Buy |
2023-10-09 | Aggiornamento | Evercore ISI | In-line → Outperform |
2023-09-15 | Iniziato | HSBC Securities | Buy |
2023-09-14 | Aggiornamento | DZ Bank | Hold → Buy |
2023-09-13 | Downgrade | JP Morgan | Overweight → Neutral |
2023-09-12 | Downgrade | Monness Crespi & Hardt | Buy → Neutral |
2023-09-05 | Aggiornamento | Barclays | Equal Weight → Overweight |
2023-08-29 | Aggiornamento | UBS | Neutral → Buy |
2023-06-13 | Aggiornamento | Goldman | Sell → Neutral |
2023-06-12 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
2023-04-20 | Reiterato | KeyBanc Capital Markets | Overweight |
2023-03-10 | Downgrade | Societe Generale | Buy → Hold |
2023-01-18 | Iniziato | DA Davidson | Neutral |
2023-01-11 | Iniziato | Mizuho | Buy |
2023-01-09 | Aggiornamento | Piper Sandler | Neutral → Overweight |
2023-01-05 | Aggiornamento | Jefferies | Hold → Buy |
2022-10-21 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
2022-10-20 | Aggiornamento | Piper Sandler | Underweight → Neutral |
2022-09-14 | Iniziato | Berenberg | Hold |
2022-08-12 | Iniziato | Guggenheim | Buy |
2022-06-29 | Aggiornamento | Exane BNP Paribas | Neutral → Outperform |
2022-06-27 | Ripresa | Goldman | Sell |
2022-06-14 | Reiterato | Monness Crespi & Hardt | Buy |
2022-04-01 | Iniziato | Daiwa Securities | Neutral |
2022-03-29 | Downgrade | Exane BNP Paribas | Neutral → Underperform |
2022-03-11 | Downgrade | Piper Sandler | Neutral → Underweight |
2022-03-11 | Aggiornamento | Societe Generale | Hold → Buy |
2021-12-21 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
2021-12-15 | Aggiornamento | DZ Bank | Sell → Hold |
2021-12-10 | Reiterato | BMO Capital Markets | Market Perform |
2021-12-10 | Reiterato | Barclays | Equal Weight |
2021-12-10 | Reiterato | Citigroup | Neutral |
2021-12-10 | Reiterato | Cowen | Outperform |
2021-12-10 | Aggiornamento | Deutsche Bank | Hold → Buy |
2021-12-10 | Reiterato | Monness Crespi & Hardt | Buy |
2021-12-10 | Reiterato | Piper Sandler | Neutral |
2021-12-10 | Reiterato | Societe Generale | Hold |
2021-12-10 | Reiterato | Stifel | Hold |
2021-12-10 | Reiterato | UBS | Neutral |
2021-12-10 | Reiterato | Wolfe Research | Peer Perform |
2021-11-16 | Iniziato | Credit Suisse | Outperform |
2021-11-02 | Iniziato | Deutsche Bank | Hold |
2021-09-14 | Reiterato | BMO Capital Markets | Market Perform |
2021-09-14 | Reiterato | Monness Crespi & Hardt | Buy |
2021-08-10 | Downgrade | DZ Bank | Hold → Sell |
2021-05-10 | Downgrade | Barclays | Overweight → Equal Weight |
2021-04-23 | Iniziato | Wolfe Research | Peer Perform |
2021-04-21 | Downgrade | DZ Bank | Buy → Hold |
2021-04-01 | Ripresa | Wedbush | Neutral |
2021-03-22 | Ripresa | Evercore ISI | In-line |
2021-03-16 | Ripresa | Credit Suisse | Outperform |
2021-03-11 | Reiterato | Monness Crespi & Hardt | Buy |
2021-03-11 | Downgrade | Societe Generale | Buy → Hold |
2021-03-05 | Aggiornamento | Barclays | Equal Weight → Overweight |
2021-03-03 | Ripresa | Citigroup | Neutral |
2021-01-22 | Iniziato | Goldman | Sell |
2020-12-18 | Aggiornamento | Monness Crespi & Hardt | Neutral → Buy |
2020-12-16 | Ripresa | BofA Securities | Neutral |
2020-12-08 | Downgrade | Cleveland Research | Buy → Neutral |
2020-11-24 | Iniziato | KeyBanc Capital Markets | Overweight |
2020-10-14 | Ripresa | UBS | Neutral |
2020-09-21 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
2020-09-11 | Reiterato | BMO Capital Markets | Market Perform |
2020-09-11 | Reiterato | Barclays | Equal Weight |
2020-09-11 | Reiterato | Credit Suisse | Outperform |
2020-09-11 | Reiterato | Goldman | Buy |
2020-09-11 | Reiterato | Jefferies | Hold |
2020-09-11 | Reiterato | Morgan Stanley | Equal-Weight |
2020-09-11 | Reiterato | RBC Capital Mkts | Outperform |
2020-09-11 | Reiterato | Stifel | Hold |
2020-09-11 | Reiterato | Wells Fargo | Overweight |
2020-06-19 | Downgrade | Argus | Buy → Hold |
2020-06-01 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
2020-03-31 | Aggiornamento | Exane BNP Paribas | Neutral → Outperform |
2020-03-20 | Aggiornamento | JP Morgan | Neutral → Overweight |
2020-03-13 | Reiterato | BMO Capital Markets | Market Perform |
Mostra tutto
Oracle Corp. Borsa (ORCL) Ultime notizie
The Zacks Analyst Blog Highlights Oracle, HSBC, RTX, Marsh & McLennan and Chipotle Mexican Grill
Zacks Investment Research
Should You Buy Advanced Micro Devices (AMD) Ahead of Q1 Earnings?
Zacks Investment Research
Earnings Season Scorecard and Analyst Reports for Oracle, HSBC & RTX
Zacks Investment Research
Oracle Corporation (ORCL) Is a Trending Stock: Facts to Know Before Betting on It
Zacks Investment Research
This Spectacular Vanguard ETF Could Turn $250 per Month Into $873,700, With Help From Artificial Intelligence (AI) Stocks Nvidia and Microsoft
The Motley Fool
Oracle (ORCL) Gains But Lags Market: What You Should Know
Zacks Investment Research
Oracle Corp. Azioni (ORCL) Dati Finanziari
Oracle Corp. (ORCL) Reddito 2024
ORCL ha riportato un ricavo (TTM) di $52.51 miliardi per il trimestre terminato il 2024-02-29, un +9.49% salita anno su anno.
Oracle Corp. (ORCL) Reddito netto 2024
ORCL l'utile netto (TTM) è stato di $10.64 miliardi per il trimestre terminato il 2024-02-29, un +27.10% aumento anno su anno.
Oracle Corp. (ORCL) Flusso di cassa 2024
ORCL ha registrato un flusso di cassa disponibile (TTM) di $12.26 miliardi per il trimestre conclusosi con 2024-02-29, un +67.96% aumento anno su anno.
Oracle Corp. (ORCL) Utile per azione 2024
L'utile per azione (TTM) di ORCL è stato pari a $3.79 per il trimestre terminato il 2024-02-29, un +25.08% crescita anno su anno.
Oracle Corp. Azioni (ORCL) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
CATZ SAFRA | Chief Executive Officer |
Mar 27 '24 |
Option Exercise |
40.47 |
810,000 |
32,779,120 |
1,928,592 |
CATZ SAFRA | Chief Executive Officer |
Mar 27 '24 |
Sale |
125.06 |
810,000 |
101,294,608 |
1,118,592 |
CATZ SAFRA | Chief Executive Officer |
Mar 26 '24 |
Option Exercise |
39.89 |
790,000 |
31,513,100 |
1,908,592 |
CATZ SAFRA | Chief Executive Officer |
Mar 26 '24 |
Sale |
126.54 |
790,000 |
99,970,313 |
1,118,592 |
CATZ SAFRA | Chief Executive Officer |
Mar 25 '24 |
Option Exercise |
40.18 |
1,150,000 |
46,210,280 |
2,268,592 |
CATZ SAFRA | Chief Executive Officer |
Mar 25 '24 |
Sale |
126.53 |
1,150,000 |
145,505,060 |
1,118,592 |
BERG JEFFREY | Director |
Mar 18 '24 |
Option Exercise |
42.02 |
45,000 |
1,890,900 |
252,409 |
BERG JEFFREY | Director |
Mar 18 '24 |
Sale |
127.80 |
45,000 |
5,750,935 |
207,409 |
HENLEY JEFFREY | Vice Chairman |
Mar 12 '24 |
Option Exercise |
40.47 |
400,000 |
16,188,000 |
1,507,916 |
HENLEY JEFFREY | Vice Chairman |
Mar 12 '24 |
Sale |
126.92 |
400,000 |
50,768,082 |
1,107,916 |
Capitalizzazione:
|
Volume (24 ore):